50242-215Level 3
Xolair PFS (omalizumab)
**Product type:** Human Prescription Drug
**Active ingredient:** OMALIZUMAB
**Strength:** 150 mg/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Genentech, Inc.
**Marketing category:** BLA (BLA103976)
**Pharmacologic class:** Anti-IgE [EPC], Decreased IgE Activity [PE], IgE-directed Antibody Interactions [MoA]
GET
/api/v1/systems/ndc_fda/nodes/50242-215Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.